TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Elos Medtech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,710,712
|
1,160,249
|
840,483 |
| Financial expenses |
63,363
|
66,052
|
33,268 |
| Earnings before taxes |
-132,197
|
-49,393
|
93,743 |
| EBITDA |
272,657
|
90,845
|
178,954 |
| Total assets |
6,464,912
|
6,340,116
|
1,345,947 |
| Current assets |
1,470,701
|
1,464,616
|
521,015 |
| Current liabilities |
392,547
|
402,416
|
147,019 |
| Equity capital |
5,004,723
|
4,843,072
|
755,297 |
| - share capital |
182,012
|
178,788
|
47,698 |
| Employees (average) |
1,566
|
774
|
626 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
77.4%
|
76.4%
|
56.1% |
| Turnover per employee |
1,731
|
1,499
|
1,343 |
| Profit as a percentage of turnover |
-4.9%
|
-4.3%
|
11.2% |
| Return on assets (ROA) |
-1.1%
|
0.3%
|
9.4% |
| Current ratio |
374.7%
|
364.0%
|
354.4% |
| Return on equity (ROE) |
-2.6%
|
-1.0%
|
12.4% |
| Change turnover |
1,529,543
|
260,127
|
156,039 |
| Change turnover % |
129%
|
29%
|
23% |
| Chg. No. of employees |
792
|
148
|
91 |
| Chg. No. of employees % |
102%
|
24%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.